Vitreoretinal Surgery
10
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
50%
5 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery
Dextenza in the Post-op Management of Vitreoretinal Surgeries
DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery
Foldable Capsular Vitreous Body Implantation Study
Comparative Study 27G Vitrectomy vs Larger Gauge Surgery
A Phase I Study of Vitargus® in Vitrectomy
Comparative Study 23G Versus 27G Vitrectomy
The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients
Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain
Brilliant Blue Versus Indocyanine Green